small intestinal L-cell glucagon-like peptide producing tumor

disease
On this page

Also known as L-cell glucagon-like peptide-producing neuroendocrine tumor of small intestineL-cell glucagon-like peptide-producing neuroendocrine tumour of small intestinesmall intestinal L-cell glucagon-like peptide-producing NETsmall intestinal L-cell glucagon-like peptide-producing neuroendocrine tumorsmall intestinal L-cell glucagon-like peptide-producing neuroendocrine tumoursmall intestinal L-cell, glucagon-like peptide-producing neuroendocrine tumorsmall intestinal L-cell, glucagon-like peptide-producing neuroendocrine tumoursmall intestine L-cell glucagon-like peptide-producing neuroendocrine tumorsmall intestine L-cell glucagon-like peptide-producing neuroendocrine tumour

Summary

small intestinal L-cell glucagon-like peptide producing tumor (MONDO:0004252) is a cancer. A subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namesmall intestinal L-cell glucagon-like peptide producing tumor
Mondo IDMONDO:0004252
DOIDDOID:7506
NCITC27452
UMLSC3274143
MedGen475776
GARD0023900
Anatomy (UBERON)UBERON:0002108
Is cancer (heuristic)yes

Also known as: L-cell glucagon-like peptide-producing neuroendocrine tumor of small intestine · L-cell glucagon-like peptide-producing neuroendocrine tumour of small intestine · small intestinal L-cell glucagon-like peptide-producing NET · small intestinal L-cell glucagon-like peptide-producing neuroendocrine tumor · small intestinal L-cell glucagon-like peptide-producing neuroendocrine tumour · small intestinal L-cell, glucagon-like peptide-producing neuroendocrine tumor · small intestinal L-cell, glucagon-like peptide-producing neuroendocrine tumour · small intestine L-cell glucagon-like peptide-producing neuroendocrine tumor · small intestine L-cell glucagon-like peptide-producing neuroendocrine tumour

Disease family

This is a subtype of small intestine neuroendocrine tumor, well differentiated, low or intermediate grade. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderdigestive system neuroendocrine neoplasmdigestive system neuroendocrine tumor, grade 1/2small intestine neuroendocrine tumor, well differentiated, low or intermediate gradesmall intestinal L-cell glucagon-like peptide producing tumor

Related subtypes (5): small intestinal neuroendocrine tumor G1, small intestinal vasoactive intestinal peptide producing tumor, duodenal neuroendocrine tumor, well differentiated, low or intermediate grade, jejunal neuroendocrine tumor, well differentiated, low or intermediate grade, ileal neuroendocrine tumor, well differentiated, low or intermediate grade

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.